Combination Therapies and Synergistic Drug Protocols
Combination therapies utilize multiple agents or treatment modalities to target cancer more effectively. By attacking tumors through different mechanisms, these approaches reduce resistance, increase efficacy, and minimize relapse. Synergistic drug protocols aim to enhance the therapeutic effect while reducing toxicity. These may include chemotherapy, targeted therapy, immunotherapy, or radiation used in tandem. For example, combining checkpoint inhibitors with kinase inhibitors has shown promise in melanoma and lung cancers. Ongoing clinical trials are refining dose schedules and identifying effective combinations. Personalized approaches based on tumor genetics and biomarkers are key to optimizing these synergistic strategies and improving patient outcomes.
Related Conference of Combination Therapies and Synergistic Drug Protocols
November 24-25, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Barcelona, Spain
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
September 29-30, 2026
5th Experts Meeting on Cancer Medicine, Radiology & Treatment
Aix-en-Provence, France
Combination Therapies and Synergistic Drug Protocols Conference Speakers
Recommended Sessions
- Artificial Intelligence and Machine Learning in Oncology
- Breast Cancer
- Cancer Case reports
- Cancer Genomics and Epigenetics
- Cancer Personalized Medicine
- Cancer Pharmacology
- Cancer Prevention and Lifestyle Interventions
- Cancer Research
- Cancer Stem Cells and Tumor Heterogeneity
- Cancer Survivorship and Long-Term Care
- Cancer Therapy
- Cancer Vaccines: Therapeutic and Preventive
- Cell and Gene Therapy for Cancer
- Combination Therapies and Synergistic Drug Protocols
- Drug Resistance in Cancer Therapy
- Financial Toxicity and Healthcare Disparities in Cancer Care
- Head and Neck Cancer
- Immunotherapy and Immune Checkpoint Inhibitors
- Liquid Biopsies and Circulating Tumor DNA (ctDNA)
- Oncolytic Viruses and Novel Biologic Therapies
- Palliative Care and Quality of Life in Cancer Patients
- Pediatric and Rare Cancers
- Personalized and Precision Oncology
- Radiomics and Imaging Innovations in Cancer Detection
- Targeted Therapy and Small Molecule Inhibitors
- Tumor Microenvironment and Cancer Metastasis
Related Journals
Are you interested in
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2026 (France)
- Advancements in Early Detection and Screening - Euro Breast Cancer 2025 (France)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Immuno-Oncology - CANCER THERAPY MEETING 2026 (France)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2026 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2026 (UAE)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Big Data in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Artificial Intelligence and Digital Health in Oncology - Euro Breast Cancer 2025 (France)
- Artificial Intelligence and Machine Learning in Oncology - Euro Cancer 2025 (France)
- Artificial Intelligence in Breast Imaging - Breast Cancer-2026 (Italy)
- Breast Cancer - Euro Cancer 2025 (France)
- Breast Cancer - Cancer Science 2026 (UAE)
- Breast Cancer and Cell Biology - Breast Cancer 2026 (UAE)
- Breast Cancer and Immunology - Breast Cancer 2026 (UAE)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Awareness - Breast Cancer 2026 (UAE)
- Breast Cancer Biomarkers and Prognosis - Breast Cancer-2026 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2026 (UAE)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2026 (UAE)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer-2026 (Italy)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Euro Breast Cancer 2025 (France)
- Breast Cancer Management - Breast Cancer 2026 (UAE)
- Breast Cancer Nursing - Breast Cancer 2026 (UAE)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention and Risk Reduction - Euro Breast Cancer 2025 (France)
- Breast Cancer Prevention Strategies - Breast Cancer-2026 (Italy)
- Breast Cancer Risk - Breast Cancer 2026 (UAE)
- Breast Cancer Staging - Breast Cancer 2026 (UAE)
- Breast Cancer Surgery - Breast Cancer 2026 (UAE)
- Breast Cancer Survivorship and Quality of Life - Breast Cancer-2026 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2026 (UAE)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Breast Reconstruction and Cosmetic Surgery - Breast Cancer-2026 (Italy)
- Cancer Awareness and Survival - World Cancer-2025 (Spain)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2026 (France)
- Cancer Case reports - Euro Cancer 2025 (France)
- Cancer Cell Biology & Genetics - World Cancer-2025 (Spain)
- Cancer Control and Prevention - Cancer Science 2026 (UAE)
- Cancer Epidemiology - World Cancer-2025 (Spain)
- Cancer Epidemiology and Prevention - CANCER THERAPY MEETING 2026 (France)
- Cancer Epigenetics - Cancer Science 2026 (UAE)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2026 (France)
- Cancer Genomics and Epigenetics - Euro Cancer 2025 (France)
- Cancer Immunology - CANCER THERAPY MEETING 2026 (France)
- Cancer Immunology & Immunotherapy - World Cancer-2025 (Spain)
- Cancer Metabolism and Therapeutic Interventions - CANCER THERAPY MEETING 2026 (France)
- Cancer Metastasis - Cancer Science 2026 (UAE)
- Cancer Nanotechnology - World Cancer-2025 (Spain)
- Cancer Personalized Medicine - Euro Cancer 2025 (France)
- Cancer Pharmacology - Euro Cancer 2025 (France)
- Cancer Pharmacology - World Cancer-2025 (Spain)
- Cancer Prevention and Lifestyle Interventions - Euro Cancer 2025 (France)
- Cancer Research - Euro Cancer 2025 (France)
- Cancer Science - Cancer Science 2026 (UAE)
- Cancer Stem Cells and Tumor Heterogeneity - Euro Cancer 2025 (France)
- Cancer Stem Cells: Understanding and Targeting - CANCER THERAPY MEETING 2026 (France)
- Cancer Survivorship and Long-Term Care - Euro Cancer 2025 (France)
- Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2026 (France)
- Cancer Therapy - Euro Cancer 2025 (France)
- Cancer Vaccines - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines: Therapeutic and Preventive - Euro Cancer 2025 (France)
- Cancer: Psychological & Social factors - World Cancer-2025 (Spain)
- Cancers & Stem Cell therapy - World Cancer-2025 (Spain)
- Cancers Biomarkers - World Cancer-2025 (Spain)
- Cancers Biomarkers - Cancer Science 2026 (UAE)
- Cancers Biopsy - World Cancer-2025 (Spain)
- Cancers Chemotherapy - World Cancer-2025 (Spain)
- Cancers Metabolomics - World Cancer-2025 (Spain)
- Cancers Metastasis - World Cancer-2025 (Spain)
- Cancers Pharmacology - Cancer Science 2026 (UAE)
- Cancers Prevention & Research - World Cancer-2025 (Spain)
- Cancers Therapy & Treatments - World Cancer-2025 (Spain)
- Cancers Vaccines - World Cancer-2025 (Spain)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2025 (Spain)
- Case Studies - Breast Cancer 2026 (UAE)
- Cell and Gene Therapy for Cancer - Euro Cancer 2025 (France)
- Cell-Based Therapy - CANCER THERAPY MEETING 2026 (France)
- Clinical Trials and New Drug Development - CANCER THERAPY MEETING 2026 (France)
- Combination Therapies and Synergistic Drug Protocols - Euro Cancer 2025 (France)
- Complementary & Alternate Methods and Cancer - World Cancer-2025 (Spain)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Spain)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Spain)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Spain)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Spain)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Spain)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Spain)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Spain)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Spain)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Spain)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Spain)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Spain)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2026 (UAE)
- Drug Development and Clinical Trials in Breast Cancer - Euro Breast Cancer 2025 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2026 (France)
- Drug Resistance in Cancer Therapy - Euro Cancer 2025 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Spain)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2026 (UAE)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Spain)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Financial Toxicity and Healthcare Disparities in Cancer Care - Euro Cancer 2025 (France)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2026 (France)
- Gene Editing & CRISPR in Cancer - World Cancer-2025 (Spain)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Global Disparities and Access to Breast Cancer Care - Euro Breast Cancer 2025 (France)
- Head and Neck Cancer - Euro Cancer 2025 (France)
- Hematology- Oncology - Cancer Science 2026 (UAE)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer Advances - Breast Cancer-2026 (Italy)
- HER2-Positive Breast Cancer: Latest Treatment Strategies - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Breast Cancer - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Subtypes - Breast Cancer-2026 (Italy)
- Immunotherapy and Breast Cancer - Breast Cancer-2026 (Italy)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Spain)
- Immunotherapy and Emerging Targeted Therapies - Euro Breast Cancer 2025 (France)
- Immunotherapy and Immune Checkpoint Inhibitors - Euro Cancer 2025 (France)
- Immunotherapy in Breast Cancer - Breast Cancer-2026 (Italy)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Spain)
- Inflammatory Breast Cancer - Breast Cancer 2026 (UAE)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2026 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2026 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsies and Circulating Tumor DNA (ctDNA) - Euro Cancer 2025 (France)
- Liquid Biopsy and Early Cancer Detection - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - Breast Cancer-2026 (Italy)
- Male Breast Cancer Research - Breast Cancer 2026 (UAE)
- Mammography - Breast Cancer 2026 (UAE)
- Metastatic Breast Cancer Management - Breast Cancer-2026 (Italy)
- Metastatic Breast Cancer: Quality of Life and Care - Euro Breast Cancer 2025 (France)
- Molecular Diagnostics and Biomarkers in Cancer - CANCER THERAPY MEETING 2026 (France)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Spain)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Nanotechnology in Cancer Diagnosis and Treatment - CANCER THERAPY MEETING 2026 (France)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Neoadjuvant and Adjuvant Therapies - Breast Cancer-2026 (Italy)
- Neonatal & Pediatric Oncology - World Cancer-2025 (Spain)
- Oncogenomics - Cancer Science 2026 (UAE)
- Oncology Nursing and Care - World Cancer-2025 (Spain)
- Oncology Nursing and Care - Cancer Science 2026 (UAE)
- Oncology Nursing: Advancements in Patient Care - CANCER THERAPY MEETING 2026 (France)
- Oncolytic Viruses and Novel Biologic Therapies - Euro Cancer 2025 (France)
- Organ-defined Cancers - World Cancer-2025 (Spain)
- Organic Specific Cancer - Cancer Science 2026 (UAE)
- Palliative Care and Quality of Life in Cancer Patients - Euro Cancer 2025 (France)
- Pediatric and Rare Cancers - Euro Cancer 2025 (France)
- Pediatric Cancer Research and Therapeutics - CANCER THERAPY MEETING 2026 (France)
- Personalized and Precision Oncology - Euro Cancer 2025 (France)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2025 (Spain)
- Precision Medicine and Genomics in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychosocial Aspects of Breast Cancer - Breast Cancer-2026 (Italy)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychosocial Support and Survivorship in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2026 (France)
- Radiation Oncology in Breast Cancer - Breast Cancer-2026 (Italy)
- Radiation Oncology: Innovations and Techniques - CANCER THERAPY MEETING 2026 (France)
- Radiation Therapy and Technological Innovations - Euro Breast Cancer 2025 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology - Breast Cancer 2026 (UAE)
- Radiomics and Imaging Innovations in Cancer Detection - Euro Cancer 2025 (France)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Spain)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Spain)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2026 (France)
- Skin Cancer - Cancer Science 2026 (UAE)
- Surgical Advances in Breast Cancer Management - Euro Breast Cancer 2025 (France)
- Surgical Innovations in Breast Cancer - Breast Cancer-2026 (Italy)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Therapy and Drug Development - Breast Cancer-2026 (Italy)
- Targeted Therapy and Precision Medicine - CANCER THERAPY MEETING 2026 (France)
- Targeted Therapy and Small Molecule Inhibitors - Euro Cancer 2025 (France)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Spain)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Spain)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Spain)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer Research - Breast Cancer-2026 (Italy)
- Triple-Negative Breast Cancer: Challenges and Innovations - Euro Breast Cancer 2025 (France)
- Tumor Biology - Cancer Science 2026 (UAE)
- Tumor Microenvironment and Cancer Metastasis - Euro Cancer 2025 (France)
- Tumor Microenvironment and Metastasis - CANCER THERAPY MEETING 2026 (France)
- Tumor Virology - Cancer Science 2026 (UAE)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2025 (Spain)
- Young Women and Breast Cancer - Breast Cancer-2026 (Italy)